Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5509-5516

  Gibbs, John P ^a   Murray, Georgia ^b   Risler, Linda ^b   Chien, Jenny Y ^a   Dev, Raj ^a   Slattery, John T ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; GLUTATHIONE TRANSFERASE; TETRAHYDROTHIOPHENIUM ION; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALKYLATION; AREA UNDER THE CURVE; ARTICLE; CHILD; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; DRUG CLEARANCE; DRUG ELIMINATION; DRUG MEGADOSE; DRUG METABOLISM; ENZYME MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

ABSORPTION; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGING; ANTINEOPLASTIC AGENTS, ALKYLATING; AREA UNDER CURVE; BUSULFAN; CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HALF-LIFE; HUMANS; INFANT; LIVER; MALE; MIDDLE AGED; THIOPHENES;

EID: 0031454073     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Forman, S. J., Blume, K. G., and Thomas, E. D. Bone Marrow Transplantation. Cambridge, MA: Blackwell Scientific Publications, 1994.
2. Grochow, L. B. Busulfan disposition: the role of therapeutic drug monitoring in bone marrow transplantation induction regimens. Semin. Oncol., 20: 18-25, 1993.
3. Slattery, J. T., Clift, R. A., Buckner, C. D., Radich, J., Storer, B., Bensinger, W. I., Soll, E., Anasetti, C., Bowden, R., Bryant, E., Chauncey, T., Deeg, H. J., Doney, K. C., Flowers, M., Gooley, T., Hansen, J. A., Martin, P. J., MacDonald, G. B., Nash, R., Petersdorf, E. W., Sanders, J. E., Schoch, G., Stewan, P., Storb, R., Sullivan, K. M., Thomas, E. D., Witherspoon, R. P., and Appelbaum, F. R. Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation. Blood, 89: 3055-3060, 1997.
4. Slattery, J. T., Sanders, J. E., Buckner, C. D., Schaffer, R. L., Lambert, K. W., Langer, F. P., Anasetti, C., Bensinger, W. I., Fisher, L. D., Appelbaum, F. R., and Hansen, J. A. Graft rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics. Bone Marrow Transplant., 16: 31-42, 1995.
5. Dix, S. P., Wingard, J. R., Mullins, R. E., Jerkunica, I., Davidson, T. G., Gilmore, C. E., York, R. C., Lin, L. S., Devine, S. M., Geller, R. B., Heffner, L. T., Hillyer, C. D., Holland, H. K., Winton, E. F., and Saral, R. Association of busulfan area under the curve with veno-occlusive disease following bone marrow transplantation. Bone Marrow Transplant., 17: 225-230, 1996.
6. Grochow, L. B., Krivit, W., Whitely, C. B., and Blazar, B. Busulfan disposition in children. Blood, 75: 1723-1727, 1990.
7. Regazzi, M. B., Locatelli, L., Buggia, I., Bonetti, F., Zecca, M., Pregnolato, M., and Quaglini, S. Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation. Clin. Pharmacol. Ther., 54: 45-52, 1993.
8. Gibaldi, M., and Perrier, D. Pharmacokinetics. New York: Marcel Dekker, Inc., 1982.
9. Marchand, D. H., Remmel, R. P., and Abdel-Monem, M. M. Biliary excretion of a glutathione conjugate of busulfan and 1,4-dibromobutane in the rat. Drug Metab. Dispos., 16: 85-92 1988.
10. 14C-busulfan in isolated perfused rat liver. Eur. J. Drug Metab. Pharmacokinet., 12: 71-76, 1987.
11. Hassan, M., Oberg, G., Ehrsson, H., Ehrnebo, M., Wallin, J., Smedmyr, B., Tonerman, T., Eksborg, S., and Simonsson, B. Pharmacokinetic and metabolic studies of high-dose busulfan in adults. Eur. J. Clin. Pharmacol., 36: 525-530, 1989.
12. Gibbs, J. P., Czerwinski, M., and Slattery, J. T. Busulfan-glutathione conjugation catalyzed by human liver cytosolic glutathione 5-transferases. Cancer Res., 56: 3678-3681, 1996.
13. Czerwinski, M., Gibbs, J. P., and Slattery, J. T. Busulfan conjugation by glutathione S-transferases α,μ, and π. Drug Metab. Dispos., 24: 1015-1019, 1996.
14. Ehrsson, H., Hassan, M., Ehrnebo, M., and Beran, M. Busulfan kinetics. Clin. Pharmacol. Ther., 34: 86-89, 1983.
15. Cotgreave, I. A., and Moldeus, P. Methodologies for the application of monobromobimane to the simultaneous analysis of soluble and protein thiol components of biological systems. J. Biochem. Biophys. Methods, 13: 231-249, 1986.
16. Lane, E. A., and Levy, R. H. Prediction of steady-state behavior of metabolite from dosing parent drug. J. Pharm. Sci., 69: 610-612, 1980.
17. Hassan, M., Ljungman, P., Ringden, O., Syruckova, Z., Bekassy, A., Stary, J., Wallin, I., and Kallberg, N. Busulfan bioavailability. Blood. 82: 2144-2150, 1995.
18. Nakkami, M. V., Trams, E. G., and Smith, P. K. Preliminary studies on the distribution and fate of TEM, TEPA, and myleran in the human. Cancer Res., 19: 713-718, 1959.
19. Vodopick, H., Hamilton, H. E., Jackson, H. L., Peng, C. T., and Sheets, R. F. Metabolic fate of tritiated busulfan in man. J. Lab. Clin. Med., 73: 266-276, 1969.
20. Rane, A. Drug disposition and action in infants and children. In. Pediatric Pharmacology, Therapeutic Principles in Practice. Philadelphia: W. B. Saunders Co., 1992.
21. Cloyd, J. C., Fischer, J. H., Kriel, R. L., and Kraus, D. M. Valproic acid pharmacokinetics in children. IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin. Pharmacol. Ther., 53: 22-29, 1993.
22. Kodama, Y., Tsutsumi, K., Kuranari, M., Kodama, H., Fujii, I., and Takeyama, M. In vivo binding characteristics of carbamazepine and carbamazepine-10,11-epoxide to serum proteins in paediatric patients with epilepsy. Eur. j. Clin. Pharmacol., 44: 291-293, 1993.
23. Grygiel, J. J., Ward, H., Ogbome, M., Goldin, A., and Birkett, D. J. Relationships between plasma theophylline clearance, liver volume, and body weight in children and adults. Eur. J. Clin. Pharmacol., 24: 529-532, 1983.
24. Murray, D. J., Crom, W. R., Reddick, W. E., Bhargava, R., and Evans, W. E. Liver volume as a determinant of drug clearance in children and adolescents. Drug Metab. Dispos., 23: 1110-1116, 1995.
25. Urata, K., Kawasaki, S., Matsunami, H., Hashikura, Y., Ikegami, T., Ishizone, S., Momose, Y., Komiyama, A., and Makuuchi, M. Calculation of child and adult standard liver volume for liver transplantation. Hepatology, 21: 1317-1321, 1995.
26. Michelet, F., Gueguen, R., Leroy, P., Wellman, M., Nicolas, A., and Siest, G. Blood and plasma glutathione measured in healthy subjects by HPLC: relation to sex, aging, biological variables, and life habits. Clin. Chem., 41: 1509-1517, 1995.
27. Loguercio, C., Tarante, D., Vitale, L. M., Beneduce, F., and Del Vecchio Blanco, C. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radical Biol. Med., 20: 483-488, 1996.
28. Adams, J. D., Lauterburg, B. H., and Mitchell, J. R. Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J. Pharmacol. Exp. Ther., 227: 749-754, 1983.
29. Peters, W. H. M., Roelofs, H. M. J., Nagengast, F. M., and Van Tongeren, J. M. Human intestinal glutathione S-transferases. Biochem. J., 257: 471-476, 1989.